3-(guanido)-1-oxo-1-hydroxy-phospholane

ID: ALA1672301

Chembl Id: CHEMBL1672301

Max Phase: Preclinical

Molecular Formula: C5H12N3O2P

Molecular Weight: 177.14

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NC1CCP(=O)(O)C1

Standard InChI:  InChI=1S/C5H12N3O2P/c6-5(7)8-4-1-2-11(9,10)3-4/h4H,1-3H2,(H,9,10)(H4,6,7,8)

Standard InChI Key:  HIQIZJHIJZMJSJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA1672301

    ---

Associated Targets(Human)

GABRA1 Tclin GABA-A receptor; alpha-1/beta-2/gamma-2 (1171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABBR1 Tclin GABA-B receptor (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRR2 Tchem GABA receptor rho-2 subunit (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRR1 Tchem GABA receptor rho-1 subunit (233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 177.14Molecular Weight (Monoisotopic): 177.0667AlogP: -0.49#Rotatable Bonds: 1
Polar Surface Area: 99.20Molecular Species: ZWITTERIONHBA: 2HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 1.74CX Basic pKa: 12.67CX LogP: -2.28CX LogD: -2.28
Aromatic Rings: Heavy Atoms: 11QED Weighted: 0.25Np Likeness Score: 0.52

References

1. Gavande N, Yamamoto I, Salam NK, Ai TH, Burden PM, Johnston GA, Hanrahan JR, Chebib M..  (2011)  Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology.,  (1): [PMID:24900248] [10.1021/ml1001344]

Source